SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Howard who wrote (73)9/8/1997 11:35:00 PM
From: chirodoc   of 569
 
<<both of these technologies are just here until something better comes along>> i agree. but don't you think that synvisc, because it will give the O/A patient 6 months, may become a standard like cortisone, NSAID's, etc., for joint pain?

i guess what i'm getting at is this. i have not invested in biox, but am considering it, although the stock has had a good run. do you think the company has enough good technology to be a long term hold (for a few years) or is this a one or two drug wonder that will be a penny stock in five years?

my personal feeling is that the THREE genzyme companies are good investments for the long haul, but questionable in short run--they have
good science and good mangement, etc.

is biox a long or short term buy at these levels? thanks for your time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext